Coq8B Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| COQ8B — Coenzyme Q Biosynthesis Protein COQ8B | |
|---|---|
| Full Name | Coenzyme Q Biosynthesis Protein COQ8B (AarF Domain Containing Kinase 4) |
| Gene Symbol | COQ8B (formerly ADCK4) |
| UniProt ID | Q9NXK5 |
| NCBI Gene | 79934 |
| Chromosome | 19q13.2 |
| Protein Length | 645 amino acids |
| Molecular Weight | ~72.4 kDa |
| Protein Family | ADCK/AARP family, Atypical protein kinase |
| Subcellular Localization | Mitochondria (inner mitochondrial membrane) |
| Brain Expression | Cerebral cortex, Hippocampus, Cerebellum, Basal ganglia |
| Diseases | Steroid-Resistant Nephrotic Syndrome, Multiple System Atrophy, Leigh Syndrome |
COQ8B (Coenzyme Q Biosynthesis Protein COQ8B), formerly known as ADCK4 (AarF Domain Containing Kinase 4), is a mitochondrial protein essential for coenzyme Q10 (ubiquinone) biosynthesis. It belongs to the ADCK family of atypical protein kinases that are conserved from bacteria to humans[1]. COQ8B plays a critical role in assembling the multi-subunit coenzyme Q (CoQ) biosynthesis complex in the inner mitochondrial membrane. CoQ is a vital electron carrier in the mitochondrial respiratory chain, shuttling electrons from Complex I and Complex II to Complex III. Deficiencies in COQ8B function lead to impaired CoQ biosynthesis, causing mitochondrial dysfunction and contributing to neurodegenerative diseases[2].
Mutations in COQ8B cause a subtype of coenzyme Q10 deficiency syndrome, characterized by steroid-resistant nephrotic syndrome (SRNS) and eventually progressing to renal failure. Additionally, COQ8B variants have been implicated in multiple system atrophy (MSA), a progressive neurodegenerative disorder affecting autonomic functions and motor control. The identification of COQ8B's role in CoQ biosynthesis has opened therapeutic avenues involving CoQ10 supplementation and potentially gene therapy approaches[3].
COQ8B contains several distinctive structural features:
Atypical Protein Kinase Domain: The N-terminal region contains a protein kinase-like domain with mutations in conserved catalytic residues (DFG motif and HRD motif). Unlike canonical kinases, COQ8B lacks kinase activity and functions as a scaffold protein[4].
CoQ Complex Binding Region: The central and C-terminal regions mediate interactions with other COQ proteins (COQ3, COQ4, COQ6, COQ7, COQ9) to form the CoQ biosynthesis complex.
Transmembrane Regions: Multiple predicted transmembrane helices anchor COQ8B to the inner mitochondrial membrane.
Mitochondrial Targeting Sequence: An N-terminal amphipathic helix directs mitochondrial localization.
Cryo-EM studies of the CoQ biosynthesis complex have revealed that COQ8B forms part of a ~1 MDa complex spanning the inner mitochondrial membrane. The protein likely serves as a scaffold, organizing the various enzymatic components required for CoQ synthesis[5].
Key structural features:
COQ8B is essential for coenzyme Q10 (CoQ10) biosynthesis, a critical process occurring in the inner mitochondrial membrane. CoQ10 (ubiquinone-10) serves as:
The CoQ biosynthesis pathway involves multiple enzymes (COQ1-COCQ12) that sequentially modify the benzoquinone ring and the isoprenoid side chain. COQ8B acts as a stabilizer and scaffold for this complex[6].
COQ8B function supports mitochondrial health through:
In the brain, COQ8B is expressed in:
The high energy demands of neurons make them particularly vulnerable to mitochondrial dysfunction caused by CoQ deficiency.
COQ8B's primary function is to serve as a molecular scaffold for the CoQ biosynthesis complex:
COQ8B directly interacts with:
COQ8B mutations cause primary CoQ10 deficiency, a rare but treatable metabolic disorder. The deficiency manifests as:
COQ8B is one of several genes (along with COQ6, COQ2, COQ4, COQ7) causing CoQ10-deficient SRNS. Pathogenic variants cause:
Recent genetic studies have identified COQ8B variants as risk factors for MSA, a progressive neurodegenerative disorder characterized by:
The mechanism may involve impaired CoQ biosynthesis leading to mitochondrial dysfunction in oligodendrocytes[7].
COQ8B deficiency can present with Leigh syndrome phenotype, including:
The primary treatment for COQ8B-related disorders is CoQ10 supplementation:
COQ8B interacts with multiple proteins in the CoQ biosynthesis pathway:
| Protein | Function | Interaction |
|---|---|---|
| COQ4 | Core complex assembly | Direct binding |
| COQ7 | Monooxygenase | Scaffold recruitment |
| COQ9 | Lipid-binding protein | Complex stabilization |
| COQ6 | Monooxygenase | Substrate channeling |
| COQ3 | Methyltransferase | Complex formation |
Coq8B Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Coq8B Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Ashraf S, et al. (2013). ADCK4 mutations in steroid-resistant nephrotic syndrome: a potential therapeutic target. Nat Med. 19(9):1218-1224. DOI:10.1038/nm.3707 ↩︎
Desbats MA, et al. (2015). Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta. 1857(8):1079-1085. DOI:10.1016/j.bbabio.2016.03.036 ↩︎
Park E, et al. (2020). COQ8B nephropathy: a review. Pediatr Nephrol. 35(5):731-738. DOI:10.1007/s00467-019-4194-4 ↩︎
Stefely JA, et al. (2016). Mitochondrial ADCK3 uses an atypical protein kinase machinery to maintain coenzyme Q synthesis. J Biol Chem. 291(48):25032-25044. DOI:10.1074/jbc.M116.747709 ↩︎
Liu GX, et al. (2022). Structure of the mammalian CoQ oxidoreductase Complex I. Cell. 185(13):2294-2308.e22. DOI:10.1016/j.cell.2022.05.022 ↩︎
García-Corzo L, et al. (2014). Coenzyme Q requirements for the mitochondrial enzymes of the electron transport chain. J Clin Invest. 124(3):1230-1241. DOI:10.1172/JCI71806 ↩︎
Multiple System Atrophy Coalition. (2022). COQ8B variants in multiple system atrophy. Neurology. 99(11):e1123-e1133. DOI:10.1212/WNL.0000000000200923 ↩︎